Reversal of doxorubicin-resistance in sarcoma 180 tumor cells by inhibition of different resistance mechanisms

Cancer Lett. 1993 Jul 16;70(3):197-202. doi: 10.1016/0304-3835(93)90231-w.

Abstract

Resistance of tumor cells to doxorubicin is a multifactorial phenomenon. In the present investigation, the ability of resistance modifiers against different resistance mechanisms was analysed. Substances which block P-glycoprotein (P-170) function circumvented resistance of doxorubicin-resistant sarcoma 180 (S180) cells completely (verapamil, thioridazine) or partially (hycanthone), whereas inhibitors of glutathione S-transferase (ethacrynic acid, N-ethylmaleimide, buthionine sulfoximine), and protein kinase C (staurosporine, acridine orange) caused only a partial reversion of resistance. In contrast, an inhibitor of alkaline phosphatase (levamisole) did not overcome doxorubicin-resistance. These results indicate that P-glycoprotein blockers might be more effective to modulate doxorubicin-resistance of S180 cells as compared to other modifiers. Further investigations using other MDR cell lines are required to clarify the generality of these findings.

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Alkaline Phosphatase / antagonists & inhibitors
  • Alkaline Phosphatase / physiology
  • Animals
  • Carrier Proteins / antagonists & inhibitors
  • Carrier Proteins / physiology
  • Catalase / physiology
  • Cell Division / drug effects
  • DNA Topoisomerases, Type II / physiology
  • Dose-Response Relationship, Drug
  • Doxorubicin / pharmacology*
  • Doxorubicin / therapeutic use
  • Drug Resistance / physiology
  • Glutathione Transferase / antagonists & inhibitors
  • Glutathione Transferase / physiology
  • Immunohistochemistry
  • Membrane Glycoproteins / antagonists & inhibitors
  • Membrane Glycoproteins / physiology
  • Protein Kinase C / antagonists & inhibitors
  • Protein Kinase C / physiology
  • Radioimmunoassay
  • Sarcoma 180 / chemistry
  • Sarcoma 180 / drug therapy*
  • Sarcoma 180 / pathology
  • Topoisomerase II Inhibitors
  • Tumor Cells, Cultured

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Carrier Proteins
  • Membrane Glycoproteins
  • Topoisomerase II Inhibitors
  • Doxorubicin
  • Catalase
  • Glutathione Transferase
  • Protein Kinase C
  • Alkaline Phosphatase
  • DNA Topoisomerases, Type II